Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.6 billion for the second quarter of 2023, which was up 5% year-over-year.
Net income attributable to Gilead was $1 billion, or $0.83 per share, compared to $1.1 billion, or $0.91 per share, last year. Adjusted EPS was $1.34.
For the full year of 2023, GAAP EPS is expected to be $4.50-4.85 while adjusted EPS is estimated to be $6.45-6.80.
Prior performance
Most Popular
Home Depot (HD) Q3 2025 Earnings: Key financials and quarterly highlights
The Home Depot (NYSE: HD) reported its third quarter 2025 earnings results today. Sales were $41.4 billion, up 2.8% from the same period a year ago. Comparable sales increased 0.2%,
Earnings Preview: Best Buy set for modest Q3 gains amid cautious outlook
Best Buy Co., Inc. (NYSE: BBY) is navigating a challenging retail backdrop, marked by cautious consumer spending and tariff-related cost pressure. The consumer electronics retailer's upcoming earnings report is expected
J.M. Smucker (SJM) anticipated to report mixed results for Q2 2026
Shares of The J.M. Smucker Co. (NYSE: SJM) stayed red on Monday. The stock has dropped 3% in the past three months. The branded foods company is scheduled to report
